CRIS
Curis Inc
Price:  
9.70 
USD
Volume:  
16,854.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRIS EV/EBITDA

-1437.8%
Upside

As of 2024-03-05, the EV/EBITDA ratio of Curis Inc (CRIS) is -0.61. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CRIS's latest enterprise value is 30.48 mil USD. CRIS's TTM EBITDA according to its financial statements is -50.08 mil USD. Dividing these 2 quantities gives us the above CRIS EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 13.1x - 17.6x 13.9x
Forward P/E multiples 17.0x - 20.8x 17.7x
Fair Price (139.85) - (145.29) (129.82)
Upside -1541.1% - -1597.2% -1437.8%
9.70 USD
Stock Price
(129.82) USD
Fair Price

CRIS EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-03-04 -0.61
2024-03-01 -0.65
2024-02-29 -0.67
2024-02-28 -0.62
2024-02-27 -0.64
2024-02-26 -0.62
2024-02-23 -0.59
2024-02-22 -0.62
2024-02-21 -0.68
2024-02-20 -0.66
2024-02-16 -0.70
2024-02-15 -0.67
2024-02-14 -0.68
2024-02-13 -0.66
2024-02-12 -0.73
2024-02-09 -0.69
2024-02-08 -0.72
2024-02-07 -0.57
2024-02-06 -0.58
2024-02-05 -0.47
2024-02-02 -0.67
2024-02-01 -0.67
2024-01-31 -0.63
2024-01-30 -0.64
2024-01-29 -0.59
2024-01-26 -0.68
2024-01-25 -0.60
2024-01-24 -0.54
2024-01-23 -0.80
2024-01-22 -0.80
2024-01-19 -0.83
2024-01-18 -0.91
2024-01-17 -0.97
2024-01-16 -0.84
2024-01-12 -0.97
2024-01-11 -1.00
2024-01-10 -1.03
2024-01-09 -1.08
2024-01-08 -1.05
2024-01-05 -0.95
2024-01-04 -1.11
2024-01-03 -1.17
2024-01-02 -0.93
2023-12-29 -0.97
2023-12-28 -1.10
2023-12-27 -1.13
2023-12-26 -1.12
2023-12-22 -1.09
2023-12-21 -0.96
2023-12-20 -0.89